0001209191-13-057711.txt : 20131218 0001209191-13-057711.hdr.sgml : 20131218 20131218162253 ACCESSION NUMBER: 0001209191-13-057711 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131216 FILED AS OF DATE: 20131218 DATE AS OF CHANGE: 20131218 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CADENCE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001333248 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8584361400 MAIL ADDRESS: STREET 1: 12481 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AKER HAZEL M CENTRAL INDEX KEY: 0001265783 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33103 FILM NUMBER: 131285439 MAIL ADDRESS: STREET 1: C/O CANCER VAX CORP STREET 2: 2110 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-12-16 0 0001333248 CADENCE PHARMACEUTICALS INC CADX 0001265783 AKER HAZEL M C/O CADENCE PHARMACEUTICALS, INC. 12481 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 0 1 0 0 SVP, GC & Secretary common stock 2013-12-16 4 M 0 13014 3.51 A 16759 D common stock 2013-12-16 4 S 0 13014 8.76 D 3745 D stock option (right to buy) 3.51 2013-12-16 4 M 0 13014 D 2022-03-14 common stock 13014 109451 D The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2013. 25% of the 155,000 shares of common stock originally subject to the option vested on 03/14/2013, and 1/48th of the remaining number of shares of common stock subject to the option vested on the first day of each full month thereafter. Not applicable to this transaction. /s/ Hazel M. Aker 2013-12-18